KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Castle Biosciences (CSTL) Deferred Taxes: 2021-2024

Historic Deferred Taxes for Castle Biosciences (CSTL) over the last 4 years, with Dec 2024 value amounting to $1.4 million.

  • Castle Biosciences' Deferred Taxes fell 97.79% to $116,000 in Q3 2025 from the same period last year, while for Sep 2025 it was -$7.6 million, marking a year-over-year decrease of 318.88%. This contributed to the annual value of $1.4 million for FY2024, which is 728.25% up from last year.
  • Castle Biosciences' Deferred Taxes amounted to $1.4 million in FY2024, which was up 728.25% from -$223,000 recorded in FY2023.
  • Over the past 5 years, Castle Biosciences' Deferred Taxes peaked at $1.4 million during FY2024, and registered a low of -$8.7 million during FY2021.
  • Over the past 3 years, Castle Biosciences' median Deferred Taxes value was -$223,000 (recorded in 2023), while the average stood at -$233,000.
  • Data for Castle Biosciences' Deferred Taxes shows a peak YoY spiked of 728.25% (in 2024) over the last 5 years.
  • Castle Biosciences' Deferred Taxes (Yearly) stood at -$8.7 million in 2021, then spiked by 78.51% to -$1.9 million in 2022, then soared by 88.12% to -$223,000 in 2023, then spiked by 728.25% to $1.4 million in 2024.